Decoy Therapeutics Inc. (DCOY) Operating cash flow 2016–2025
Decoy Therapeutics Inc. (DCOY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.8MFY2025 · since FY2016: -$32.1M → -$4.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$4.8M | -6.7% |
| FY2024 | -$4.5M | +64.8% |
| FY2023 | -$12.8M | +27.0% |
| FY2022 | -$17.6M | -72.5% |
| FY2021 | -$10.2M | +1.1% |
| FY2020 | -$10.3M | +11.0% |
| FY2019 | -$11.6M | -377.2% |
| FY2018 | $4.2M | +115.1% |
| FY2017 | -$27.7M | +13.5% |
| FY2016 | -$32.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DCOY financial trends
DCOY RevenueDCOY Net incomeDCOY Net marginDCOY Gross profitDCOY Gross marginDCOY Operating incomeDCOY Operating marginDCOY Free cash flowDCOY Capital expendituresDCOY Return on equityDCOY Stock buybacksDCOY Dividends paidDCOY Total assetsDCOY Total liabilitiesDCOY Shareholders’ equityDCOY overview →